Login / Signup

Emerging and traditional 5-α reductase inhibitors and androgen receptor antagonists for male androgenetic alopecia.

Aditya Kumar GuptaMesbah TalukderGreg Williams
Published in: Expert opinion on emerging drugs (2024)
Although several newer 5-ARIs, ARAs, and natural products have exhibited promise in clinical trials, additional research is essential to confirm their safety and efficacy in treating male AGA. Until additional evidence is available for these agents, the preferred treatment choices for male AGA are the FDA-approved treatments, topical minoxidil, and oral finasteride.
Keyphrases
  • clinical trial
  • combination therapy
  • open label
  • artificial intelligence
  • platelet rich plasma